I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 17 studies | 33% ± 15% | |
| endothelial cell | 16 studies | 30% ± 11% | |
| macrophage | 12 studies | 22% ± 7% | |
| fibroblast | 10 studies | 23% ± 8% | |
| pericyte | 9 studies | 23% ± 4% | |
| epithelial cell | 8 studies | 39% ± 20% | |
| endothelial cell of lymphatic vessel | 7 studies | 20% ± 5% | |
| smooth muscle cell | 7 studies | 22% ± 5% | |
| basal cell | 7 studies | 32% ± 14% | |
| mast cell | 6 studies | 26% ± 7% | |
| astrocyte | 6 studies | 23% ± 7% | |
| classical monocyte | 5 studies | 23% ± 6% | |
| glutamatergic neuron | 5 studies | 32% ± 18% | |
| goblet cell | 5 studies | 26% ± 14% | |
| non-classical monocyte | 4 studies | 28% ± 8% | |
| conventional dendritic cell | 4 studies | 26% ± 8% | |
| connective tissue cell | 4 studies | 20% ± 4% | |
| microglial cell | 4 studies | 20% ± 3% | |
| club cell | 4 studies | 26% ± 4% | |
| Mueller cell | 4 studies | 22% ± 3% | |
| respiratory goblet cell | 4 studies | 23% ± 11% | |
| natural killer cell | 3 studies | 19% ± 4% | |
| pancreatic A cell | 3 studies | 37% ± 8% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 19% ± 1% | |
| capillary endothelial cell | 3 studies | 16% ± 1% | |
| neuron | 3 studies | 29% ± 10% | |
| myofibroblast cell | 3 studies | 23% ± 4% | |
| myeloid cell | 3 studies | 28% ± 8% | |
| squamous epithelial cell | 3 studies | 46% ± 23% | |
| retina horizontal cell | 3 studies | 23% ± 7% | |
| lymphocyte | 3 studies | 23% ± 7% | |
| secretory cell | 3 studies | 27% ± 10% | |
| endothelial cell of vascular tree | 3 studies | 20% ± 5% | |
| GABAergic neuron | 3 studies | 37% ± 12% | |
| abnormal cell | 3 studies | 24% ± 6% | |
| enteroendocrine cell | 3 studies | 23% ± 9% | |
| intestinal crypt stem cell | 3 studies | 17% ± 2% | |
| transit amplifying cell | 3 studies | 22% ± 7% | |
| oligodendrocyte | 3 studies | 24% ± 6% |
